139 related articles for article (PubMed ID: 21922366)
1. Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a case.
Mimatsu K; Oida T; Kawasaki A; Kano H; Fukino N; Kida K; Kuboi Y; Amano S
Surg Today; 2011 Oct; 41(10):1410-3. PubMed ID: 21922366
[TBL] [Abstract][Full Text] [Related]
2. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H
Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654
[TBL] [Abstract][Full Text] [Related]
3. Biliary intraductal papillary mucinous neoplasia: three case reports.
Yaman B; Nart D; Yilmaz F; Coker A; Zeytunlu M; Kilic M
Virchows Arch; 2009 May; 454(5):589-94. PubMed ID: 19347361
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
5. Intestinal obstruction caused by colonic metastasis from intrahepatic cholangiocarcinoma 6 years after removal of the primary tumor: report of a case.
Tokodai K; Kawagishi N; Miyagi S; Takeda I; Sato K; Akamatsu Y; Sekiguchi S; Ishida K; Satomi S
Surg Today; 2012 Aug; 42(8):797-800. PubMed ID: 22307905
[TBL] [Abstract][Full Text] [Related]
6. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.
Matsumura N; Yamamoto M; Aruga A; Takasaki K; Nakano M
Cancer; 2002 Mar; 94(6):1770-6. PubMed ID: 11920540
[TBL] [Abstract][Full Text] [Related]
7. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic mucinous cholangiocarcinoma.
Lin BY; Wu CC; Tsai TH
Kaohsiung J Med Sci; 2020 Sep; 36(9):757-758. PubMed ID: 32492241
[No Abstract] [Full Text] [Related]
9. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
10. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.
Boonla C; Sripa B; Thuwajit P; Cha-On U; Puapairoj A; Miwa M; Wongkham S
World J Gastroenterol; 2005 Aug; 11(32):4939-46. PubMed ID: 16124042
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
14. Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor.
Izzo F; Piccirillo M; Albino V; Botti G; Foggia M; Iodice R; Pagano F; Piccirillo G; Tornillo L; Delrio P
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):892-4. PubMed ID: 19550345
[TBL] [Abstract][Full Text] [Related]
15. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
Imai K; Yamamoto M; Ariizumi S
Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
17. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
18. Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver.
Lim JH; Kim YI; Park CK
Abdom Imaging; 2000; 25(1):89-92. PubMed ID: 10652930
[TBL] [Abstract][Full Text] [Related]
19. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
20. Recurrence after surgical resection of intrahepatic cholangiocarcinoma.
Yamamoto M; Takasaki K; Otsubo T; Katsuragawa H; Katagiri S
J Hepatobiliary Pancreat Surg; 2001; 8(2):154-7. PubMed ID: 11455472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
